7
WE FIND SYNERGY IN HEALTHCARE TEASER *2018 FY UZBEKISTAN PHARMACEUTICAL MARKET OVERVIEW 4Q 2018

UZBEKISTANreports.upharma-c.com/pdf/Uzbekistan.pdf · SWOT Analysis 15 8. Pricing Mark-ups: Wholesale and Retail 15 III. Major Local Pharmaceutical Companies 16 IV. Regulation of

  • Upload
    others

  • View
    4

  • Download
    0

Embed Size (px)

Citation preview

Page 1: UZBEKISTANreports.upharma-c.com/pdf/Uzbekistan.pdf · SWOT Analysis 15 8. Pricing Mark-ups: Wholesale and Retail 15 III. Major Local Pharmaceutical Companies 16 IV. Regulation of

W E F I N D S Y N E R G Y I N H E A L T H C A R E

TEASER *2018 FY

UZBEKISTAN

PHARMACEUTICALMARKET OVERVIEW

4Q 2018

Page 2: UZBEKISTANreports.upharma-c.com/pdf/Uzbekistan.pdf · SWOT Analysis 15 8. Pricing Mark-ups: Wholesale and Retail 15 III. Major Local Pharmaceutical Companies 16 IV. Regulation of

The report uncovers 2016-2018 business trends of the pharmaceutical market and healthcare industry in Uzbekistan, its epidemiology and demographics. It is designed for industry executives, decision makers, sales & marketing and market access managers and other stakeholders.The Overview will be useful for top-managers, business owners, consultants and other stakeholders of the Life Sciences industry, who are analyzing, planning to enter or invest into the Uzbek pharma and healthcare market.The Overview covers the 2012-2018 FY data for the pharmaceutical market and includes forecast for 2019-2021.

REPORT ABOUT

CONTENTSI. Uzbekistan Country Overview 06

1. Country Snapshot 06

2. Economy of Uzbekistan in 2017-2018 06

3. Uzbekistan’s Social-Political Development 08

4. Economy Outlook for 2019-2021 08

II. Pharmaceutical Market of Uzbekistan in 4Q 2018 091. Industry Summary 092. Market Structure 103. Supply Chain 104. Market Segments 115. Pharmaceutical Market Forecast for 2019-2021 116. PESTLE Analysis Impact Map 147. SWOT Analysis 158. Pricing Mark-ups: Wholesale and Retail 15

III. Major Local Pharmaceutical Companies 16IV. Regulation of the Pharmaceutical Sphere 18V. Healthcare Sphere in 2017 20

1. Healthcare System Summary 202. Healthcare System Financing 203. Healthcare Infrastructure 20

VI. Epidemiology 23VII. Demographics 25Abbreviations and Definitions 27

List of Tables Used 28

List of Graphs Used 29

Page 3: UZBEKISTANreports.upharma-c.com/pdf/Uzbekistan.pdf · SWOT Analysis 15 8. Pricing Mark-ups: Wholesale and Retail 15 III. Major Local Pharmaceutical Companies 16 IV. Regulation of

EXAMPLE PAGES

Page 4: UZBEKISTANreports.upharma-c.com/pdf/Uzbekistan.pdf · SWOT Analysis 15 8. Pricing Mark-ups: Wholesale and Retail 15 III. Major Local Pharmaceutical Companies 16 IV. Regulation of
Page 5: UZBEKISTANreports.upharma-c.com/pdf/Uzbekistan.pdf · SWOT Analysis 15 8. Pricing Mark-ups: Wholesale and Retail 15 III. Major Local Pharmaceutical Companies 16 IV. Regulation of

LIST OF TABLES USEDpage List of tables

6 TABLE 1. Uzbekistan: Country Snapshot

7 TABLE 2. Key Macroeconomic Indicators of Uzbekistan in 2013-2018; 2019-2021 (f)

8 TABLE 3. Uzbekistan in the Key International Ratings, 2018-2019

12 TABLE 4. TOP-15 Pharmaceutical Companies on the Pharmaceutical Market of Uzbekistan in 2018, total market

13 TABLE 5. TOP-15 Products on the Pharmaceutical Market of Uzbekistan in 2018, total market

20 TABLE 6. Number of Outpatient Clinics in Uzbekistan by Regions in 2016-2017

21 TABLE 7. Total State Budget & Budget on the Healthcare in Uzbekistan, 2014-2018

21 TABLE 8. Number of Hospitals and Hospital Beds in Uzbekistan by regions in 2016-2017

22 TABLE 9. Number of Doctors by specialization (thousand people) in 2012-2017

22 TABLE 10. Number of Doctors by Regions (thousand people) in 2012-2016

23 TABLE 11. Morbidity of the Population by Main Cases in 2017, thousand cases

23 TABLE 12. Morbidity of the Population by Main Cases in 2017, thousand cases

24 TABLE 13. Mortality by Main Groups of Causes in Uzbekistan, 2016-2017, ths cases

25 TABLE 14. Number of Urban and Rural Population in Uzbekistan in 2019 (beginning of year) by regions, thou.

26 TABLE 15. Labor resources in Uzbekistan (average annual) in 2013-2017, thou.

26 TABLE 16. Population of Uzbekistan in 20142019 (beginning of year) by regions, thou.

Page 6: UZBEKISTANreports.upharma-c.com/pdf/Uzbekistan.pdf · SWOT Analysis 15 8. Pricing Mark-ups: Wholesale and Retail 15 III. Major Local Pharmaceutical Companies 16 IV. Regulation of

LIST OF GRAPHS USEDpage List of graphs

7 GRAPH 1. Graph 1. Real GDP Growth compared to Fiscal Balance and Current Account Balance in 2011-2018

8 GRAPH 2. Official Average Annual Exchange Rates. 2011-2018

9 GRAPH 3. Total Pharmaceutical Market Sales in Uzbekistan in 2013-2018, values, (mio USD)

9 GRAPH 4. Total Pharmaceutical Market Sales in Uzbekistan in 2013-2018, volumes, (mio units)

10 GRAPH 5. Weighted Average Cost of a Pack in 2013-2018, total market, US $ per pack

10 GRAPH 6. Manufacturing of basic pharmaceutical products and drugs in Uzbekistan, 2012-2018

11 GRAPH 7. Pharmaceutical Market of Uzbekistan Forecast for 2019-2021, values (USD mio)

11 GRAPH 8. Pharmaceutical Market of Uzbekistan Forecast for 2019-2021, volumes (units mio)

Page 7: UZBEKISTANreports.upharma-c.com/pdf/Uzbekistan.pdf · SWOT Analysis 15 8. Pricing Mark-ups: Wholesale and Retail 15 III. Major Local Pharmaceutical Companies 16 IV. Regulation of

How to buy tHis report:

Alexey KlochKoLife ScienceS MarketS [email protected]

eugene BrovKopartner, BuSineSS conSuLting & inSightS+380 (98) [email protected]

40th Hlybochytska str., building F, office 401, Kyiv, 04050, Ukraine

Tel.:+380 (44) 232-11-43+380 (44) 232-11-42

E-mail:[email protected]/en

W E F I N D S Y N E R G Y I N H E A L T H C A R E

For additional informations, please, contacts us:

Follow the link to request an invoice

Check out our other reports:

Check out our new reports: